Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Hikal LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code:524735NSE Symbol: HIKALP/E(TTM):53.66
ISIN Demat:INE475B01022Div & Yield %:0.38EPS(TTM):5.82
Book Value(Rs):92.8761707Market Cap ( Cr.):3850.68Face Value(Rs):2
    Change Company 
( In Cr)
 Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
INCOME :      
Sales Turnover 2023.031942.721720.441507.261589.611300.09
Excise Duty0.000.000.000.000.004.00
Net Sales2023.031942.721720.441507.261589.611296.09
Other Income 5.414.894.983.702.264.46
Stock Adjustments 14.5635.82-1.675.5814.9816.34
Total Income2043.001983.431723.751516.541606.851316.89
EXPENDITURE :      
Raw Materials 1121.591032.21906.71781.90868.80715.32
Power & Fuel Cost186.91175.46147.83129.99132.04108.41
Employee Cost 220.40201.35164.32156.57135.69128.06
Other Manufacturing Expenses 114.60106.3791.2793.7190.2455.36
Selling and Administration Expenses 110.01101.3164.0555.5652.5045.90
Miscellaneous Expenses 27.0221.2821.7137.3527.1917.66
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure1780.531637.981395.881255.081306.461070.70
Operating Profit262.47345.46327.87261.46300.40246.21
Interest 48.1031.2236.2052.4258.4349.12
Gross Profit214.37314.24291.67209.04241.97197.09
Depreciation109.0195.6785.2582.4692.8885.59
Profit Before Tax105.36218.57206.42126.58149.09111.50
Tax30.4859.6579.5534.7045.5044.70
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-3.49-1.59-6.277.440.51-10.43
Reported Net Profit78.38160.51133.1484.44103.0877.23
Extraordinary Items 0.450.140.01-10.36-0.020.00
Adjusted Net Profit77.93160.37133.1394.80103.1077.23
Adjst. below Net Profit -0.601.19-1.44-4.19-2.65-2.14
P & L Balance brought forward804.60670.03553.12492.61405.75341.33
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 12.3327.1314.8019.7313.5610.69
P & L Balance carried down870.05804.60670.03553.12492.61405.73
Dividend0.000.002.4712.337.400.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %60.0080.00100.0060.0060.0060.00
Earnings Per Share-Unit Curr6.3613.0210.806.858.369.40
Earnings Per Share(Adj)-Unit Curr6.3613.0210.806.858.366.27
Book Value-Unit Curr91.9386.6275.7066.2261.3381.43